Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brieger

Showing results (161-170 of 245) with videos related to

Pageof 25
Sort By:
BMC Health Services Research|November 10, 2016
The household economic burden for acute coronary syndrome survivors in AustraliaKarice K Hyun, Beverley M Essue, Mark Woodward, et al.
American Heart Journal|June 23, 2007
Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Brian M Kennelly, et al.
Journal of the American Heart Association|November 2, 2019
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?Stephen T Vernon, Sean Coffey, Mario D'Souza, et al.
American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.
Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 14, 2018
Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registryRong Bing, Shaun G Goodman, Andrew T Yan, et al.
European Heart Journal. Acute Cardiovascular Care|December 16, 2014
High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causalityDerek P Chew, Tom G Briffa, Nasser J Alhammad, et al.
Heart, Lung & Circulation|July 1, 2020
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 PandemicWilliam A Parsonage, Louise Cullen, David Brieger, et al.
International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.
BMC Medical Informatics and Decision Making|March 9, 2021
Combining structured and unstructured data in EMRs to create clinically-defined EMR-derived cohortsCharmaine S Tam, Janice Gullick, Aldo Saavedra, et al.
Pageof 25

Showing results (161-170 of 245) with videos related to

Sort By:
Pageof 25
BMC Health Services Research|November 10, 2016
The household economic burden for acute coronary syndrome survivors in AustraliaKarice K Hyun, Beverley M Essue, Mark Woodward, et al.
American Heart Journal|June 23, 2007
Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Brian M Kennelly, et al.
Journal of the American Heart Association|November 2, 2019
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?Stephen T Vernon, Sean Coffey, Mario D'Souza, et al.
American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.
Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 14, 2018
Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registryRong Bing, Shaun G Goodman, Andrew T Yan, et al.
European Heart Journal. Acute Cardiovascular Care|December 16, 2014
High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causalityDerek P Chew, Tom G Briffa, Nasser J Alhammad, et al.
Heart, Lung & Circulation|July 1, 2020
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 PandemicWilliam A Parsonage, Louise Cullen, David Brieger, et al.
International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.
BMC Medical Informatics and Decision Making|March 9, 2021
Combining structured and unstructured data in EMRs to create clinically-defined EMR-derived cohortsCharmaine S Tam, Janice Gullick, Aldo Saavedra, et al.
Pageof 25